Tandem Diabetes Care Inc (NASDAQ: TNDM) on Tuesday, soared 7.03% from the previous trading day, before settling in for the closing price of $16.37. Within the past 52 weeks, TNDM’s price has moved between $9.98 and $38.28.
Annual sales at Healthcare sector company slipped by -28.23% over the past five years. The company achieved an average annual earnings per share of -44.71%. With a float of $67.12 million, this company’s outstanding shares have now reached $67.77 million.
Tandem Diabetes Care Inc (TNDM) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Tandem Diabetes Care Inc is 1.01%, while institutional ownership is 116.91%. The most recent insider transaction that took place on Aug 11 ’25, was worth 102,318. In this transaction PRESIDENT & CEO of this company bought 10,000 shares at a rate of $10.23, taking the stock ownership to the 106,327 shares. Before that another transaction happened on Aug 08 ’25, when Company’s EVP & CHIEF FINANCIAL OFFICER bought 13,720 for $10.89, making the entire transaction worth $149,404. This insider now owns 25,580 shares in total.
Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.44 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.24) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -44.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.90% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Tandem Diabetes Care Inc (TNDM) is currently performing well based on its current performance indicators. A quick ratio of 1.90 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.05, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (NASDAQ: TNDM) saw its 5-day average volume 3.45 million, a positive change from its year-to-date volume of 1.79 million. As of the previous 9 days, the stock’s Stochastic %D was 86.83%.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 67.32%, which indicates a significant decrease from 82.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.95 in the past 14 days, which was higher than the 0.83 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.85, while its 200-day Moving Average is $18.57. Nevertheless, the first resistance level for the watch stands at $18.48 in the near term. At $19.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.49. If the price goes on to break the first support level at $16.47, it is likely to go to the next support level at $15.43. Assuming the price breaks the second support level, the third support level stands at $14.46.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
Market capitalization of the company is 1.19 billion based on 67,569K outstanding shares. Right now, sales total 940,200 K and income totals -96,030 K. The company made 249,250 K in profit during its latest quarter, and -21,170 K in sales during its previous quarter.
